- Document41768812571585916287încărcat deNeeraj
- Document26879905961586019971încărcat deNeeraj
- Document83365478721590242273încărcat deNeeraj
- Document48798351201589011393încărcat deNeeraj
- Document68438422411589009073încărcat deNeeraj
- DocumentNational Centre for Diseasesîncărcat deNeeraj
- Document46605676301592998624încărcat deNeeraj
- DocumentNational Centre for Disease Controlîncărcat deNeeraj
- DocumentConsolidated Travel Advisory Updated 11032020încărcat deNeeraj
- DocumentGuidelines for International Arrivals 17022021încărcat deNeeraj
- DocumentGuidelines for International Arrivals 17022021încărcat deNeeraj
- DocumentAlgorithm for International Arrivalsîncărcat deNeeraj
- DocumentQ3A(R2) Guidelineîncărcat deNeeraj
- DocumentQ3B(R2) Guidelineîncărcat deNeeraj
- DocumentQ3B(R2) Concept Paperîncărcat deNeeraj
- DocumentWorkPlan_2020_0915încărcat deNeeraj
- DocumentQ2(R1) Guidelineîncărcat deNeeraj
- DocumentQ2R2-Q14 EWG Concept Paperîncărcat deNeeraj
- DocumentQ2R2-Q14 EWG Business Planîncărcat deNeeraj
- DocumentFORMULATION AND EVALUATION OF MONTELUKAST SODIUM AND LEVOCETIRIZINE DIHYDROCHLORIDE SUBLINGUAL TABLETSîncărcat deNeeraj
- DocumentFORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF BUCOADHESIVE TABLET OF CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE IN COMBINED DOSAGE FORMîncărcat deNeeraj
- DocumentDuijvestijn Et Al-2009-Cochrane Database of Systematic Reviewsîncărcat deNeeraj
- Documentmoncoinsante.pdfîncărcat deNeeraj
- DocumentMon Coins Anteîncărcat deNeeraj